Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)
Clinical trial NCT04554966 · COMPLETED
Trial details
- NCT number
- NCT04554966
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2023-08-14
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.